This week saw a nice pickup thanks again to AI. Four companies raised nine-figure rounds and there were several other big rounds just under that. Of...
Health, Wellness & Biotech
Judging by its 2023 reported investment activity, it seems Andreessen Horowitz is a lot less bullish than in recent past years.
San Francisco- and London-based Aiolos Bio, a newly launched startup with an asthma drug in clinical trials, announced that it raised $245 million in...
There is only one way to describe this week 鈥� incredibly slow. For the first time in a while, there wasn鈥檛 a round that hit nine figures. After a...
At least 20 global companies made debuts on the Nasdaq and NYSE in 2021 at initial valuations above $10 billion. Since then, some buzzy names have...
Once again no single investor really dominated the list in September with only one making more than a dozen deals, and just two reaching double...
For weeks it seemed like investors couldn鈥檛 take part in enough nine-figure rounds. Well, that all stopped this week, as only one round topped $100...
The big rounds ran the gamut, from parking (yes, parking!) to energy to good ol' AI.
AI, space and biotech were the big winners, raising more than $2 billion in the top five rounds. The last several weeks have definitely seen the big...
There were two raises of $1 billion or more this month, and it took at least $210 million to make this list. Of course, AI played a role.
So far in 2023, Seattle-based startups have pulled in $1.1 billion in seed through growth-stage financing, per 91精品 data. That鈥檚 a decline of...
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers